Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Kingston Health Sciences Centre currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 3 distinct examiners. Furthermore, these proceedings are distributed across 3 distinct art units, indicating that applications are being reviewed in different administrative sections of the patent office.
SCHAETZLE, KENNEDY is the busiest examiner for the portfolio, currently managing 1 pending office action assigned to the busiest examiner. This represents a portion of the 3 total pending office actions for the organization. The distribution between the 3 pending office actions, 3 distinct examiners, and 3 distinct art units suggests a diversified prosecution landscape for the company's Biotechnology & Pharmaceuticals interests.
Practitioners should note that with 3 distinct art units involved, the company's filings are not concentrated in a single technical niche. SCHAETZLE, KENNEDY and the other examiners provide a spread of oversight that requires attention to different procedural styles. This distribution ensures that the 3 pending office actions are subject to independent review processes across different specialized units within the patent office.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHAETZLE, KENNEDY | 1 | 83.8% | +8.1% |
| SALMON, KATHERINE D | 1 | 42.8% | +37.9% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015989 | Methods for Classifying Cancer | SALMON, KATHERINE D | 31d overdue |
| 18585270 | Sequential Mapping of Cardiac Arrhythmia without Fiducial Time Reference | SCHAETZLE, KENNEDY | 54d |
| 17281809 | Prostate Cancer Biomarker Assays | JONES, CHRISTINE MICHELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015989 | Methods for Classifying Cancer | SALMON, KATHERINE D | 31d overdue |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| 1682 | 1 |
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18585270 | Sequential Mapping of Cardiac Arrhythmia without Fiducial Time Reference | SCHAETZLE, KENNEDY | 3796 | §101Other | Final Rejection | 54d | Pending | Feb 23, 2024 |
| 18015989 | Methods for Classifying Cancer | SALMON, KATHERINE D | 1682 | §101§102§103 | Final Rejection | 31d overdue | Pending | Jan 13, 2023 |
| 17281809 | Prostate Cancer Biomarker Assays | JONES, CHRISTINE MICHELLE | 1600 | §103 | Final Rejection | — | Pending | Dec 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial